{"nctId":"NCT02570321","briefTitle":"Cross-linking for Corneal Ulcers Treatment Trial","startDateStruct":{"date":"2015-11","type":"ACTUAL"},"conditions":["Corneal Ulcer","Infectious Keratitis","Bacterial Ulcer","Fungal Ulcer"],"count":147,"armGroups":[{"label":"Bacterial ulcer cross-linking","type":"EXPERIMENTAL","interventionNames":["Procedure: Corneal Cross-linking"]},{"label":"Bacterial ulcer control","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Corneal Cross-linking"]},{"label":"Fungal ulcer cross-linking plus natamycin","type":"EXPERIMENTAL","interventionNames":["Procedure: Corneal Cross-linking","Drug: Anti Fungal Drug"]},{"label":"Fungal ulcer control with natamycin","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Corneal Cross-linking","Drug: Anti Fungal Drug"]},{"label":"Fungal ulcer cross-linking plus amphotericin","type":"EXPERIMENTAL","interventionNames":["Procedure: Corneal Cross-linking","Drug: Anti Fungal Drug"]},{"label":"Fungal ulcer control with amphotericin","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Corneal Cross-linking","Drug: Anti Fungal Drug"]}],"interventions":[{"name":"Corneal Cross-linking","otherNames":[]},{"name":"Anti Fungal Drug","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n* Corneal ulcer that is smear positive for either bacteria or filamentous fungus\n* Pinhole visual acuity worse than 20/70 in the affected eye\n* Not treated already with antimicrobial medications at presentation\n* Age over 18 years\n* Basic understanding of the study as determined by the physician\n* Commitment to return for follow up visits\n\nExclusion criteria:\n\n* Evidence of concomitant infection on exam or gram stain (i.e. herpes, both bacteria and acanthamoeba on gram stain)\n* Impending or frank perforation at recruitment\n* Involvement of sclera at presentation\n* Non-infectious or autoimmune keratitis\n* History of corneal transplantation or recent intraocular surgery\n* No light perception in the affected eye\n* Pinhole visual acuity worse than 20/200 in the unaffected eye\n* Participants who are decisionally and/or cognitively impaired","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Microbiological Cure on Repeat Culture","description":"Corneal scraping of the ulcer will be performed and directly inoculated on to sheep's blood agar, chocolate agar, potato dextrose agar or Sabouraud's agar for bacterial and fungal culture. Microbiological cure is defined as no growth of bacteria or fungus on these media.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"17","spread":null},{"groupId":"OG003","value":"14","spread":null},{"groupId":"OG004","value":"15","spread":null},{"groupId":"OG005","value":"13","spread":null}]},{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"9","spread":null},{"groupId":"OG003","value":"12","spread":null},{"groupId":"OG004","value":"12","spread":null},{"groupId":"OG005","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Best Spectacle-corrected Visual Acuity","description":"Best corrected visual acuity will be measured at baseline for both eyes using the standard ETDRS chart light box at the 4- and 1-meter test distances. In the case that the patient reads less than 10 letters at 4 meters, move the patient or the chart to a distance of 1 meter from the patient.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":null},{"groupId":"OG001","value":"1.32","spread":null},{"groupId":"OG002","value":"0.43","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0.48","spread":null},{"groupId":"OG005","value":"0.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Scar Size","description":"Study clinician will measure infiltrate or scar size using a standardized protocol with the slit lamp biomicroscope. The geometric mean of the scar size will be measured by recording the horizontal and vertical diameter.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null},{"groupId":"OG001","value":"3.0","spread":null},{"groupId":"OG002","value":"3.0","spread":null},{"groupId":"OG003","value":"3.9","spread":null},{"groupId":"OG004","value":"3.5","spread":null},{"groupId":"OG005","value":"3.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Adverse Events Including Rate of Perforation/Need for Therapeutic Penetrating Keratoplasty","description":"Adverse events include glaucoma, endophthalmitis, medication reaction, perforation including treatment by therapeutic penetrating keratoplasty.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"4","spread":null},{"groupId":"OG005","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"5","spread":null},{"groupId":"OG004","value":"5","spread":null},{"groupId":"OG005","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"1","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Vision Related Quality of Life","description":"Mobility subscale: As measured by the Indian Visual Function Questionnaire (IVFQ) which records quality of life on a scale of 0 to 100 with 100 representing the best quality of life.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"89.6","spread":null},{"groupId":"OG003","value":"91.7","spread":null},{"groupId":"OG004","value":"95.8","spread":null},{"groupId":"OG005","value":"89.6","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":19},"commonTop":["Median tarsorrhaphy"]}}}